Publication | Closed Access

GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial

Hematological MalignancyMedicineImmunologyImmunotherapyOncologyRadiation OncologyRefractory Multiple MyelomaMyeloid Neoplasia